Evaluation of PXL065 - deuterium-stabilized (R)-pioglitazone in patients with NASH: A phase II randomized placebo-controlled trial (DESTINY-1). Harrison SA, Thang C, Bolze S, Dewitt S, et al. J Hepatol 2023;78:914-925.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Harrison SA, Thang C, Bolze S, Dewitt S, et al. Evaluation of PXL065 - deuterium-stabilized (R)-pioglitazone in patients with NASH: A phase II randomized placebo-controlled trial (DESTINY-1). J Hepatol 2023;78:914-925.
PMID: 36804402

Free Medical Abstracts
Privacy Policy